Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
6.93
+2.12 (44.07%)
At close: Sep 15, 2025, 4:00 PM EDT
6.65
-0.28 (-4.04%)
After-hours: Sep 15, 2025, 6:24 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
Novel Small Molecule Precision Medicines
75.62M

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
75.62M